
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States. We market Qelbree (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in...
Cns,epilepsy,migraine,parkinson's disease,cervical dystonia,and chronic sialorrhea
Supernus pharmaceuticals, inc operates in the Pharmaceutical manufacturing industry.
Supernus pharmaceuticals, inc's revenue is 501m - 1b
Supernus pharmaceuticals, inc has 501 - 1000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.